This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
4 Top-Performing Liquid Stocks to Strengthen Portfolio Returns
by Vaishali Doshi
Investors can boost returns by adding top-ranked liquid stocks such as Avino Silver, CommScope, EverQuote and Willdan to their portfolios.
Is EverQuote (EVER) Stock a Solid Choice Right Now?
by Zacks Equity Research
EverQuote (EVER) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
EVER Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
EverQuote remains poised to gain from its exclusive data asset and technology, intensified focus on core P&C markets and strong financial profile.
Here's Why You Should Retain Hartford Insurance Stock for Now
by Zacks Equity Research
HIG remains well-poised for growth on the back of rate increases, new business growth and sound operating cash flows.
Bet on Winning DuPont Analysis & Pick 4 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), EMCOR Group (EME), Expeditors International of Washington (EXPD) and Sprouts Farmers Market (SFM).
EG Lags Industry, Trades at a Discount: What Should Investors Do Now?
by Zacks Equity Research
Everest Group remains poised to gain from strong renewal retention, continued favorable rate increases and prudent capital deployment.
Compelling Reasons to Hold on to Marsh & McLennan Stock
by Zacks Equity Research
MMC remains well-poised on robust segmental contribution, strong renewal rates and prudent deployment of capital.
MetLife Joins SKYGEN to Revolutionize Dental Provider Experience
by Zacks Equity Research
MET partners with SKYGEN to simplify dental credentialing, enhance efficiency, and improve the provider experience.
EverQuote (EVER) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wall Street Analysts See a 27.37% Upside in EverQuote (EVER): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 27.4% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Why Is EverQuote (EVER) Up 16% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bet on DuPont Analysis & Pick 5 Quality Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap AllianceBernstein (AB), EverQuote (EVER), EMCOR Group (EME), Blue Bird (BLBD) and Sprouts Farmers Market (SFM).
ROOT Zooms Past S&P 500: Should You Buy Despite Premium Valuation?
by Tanuka De
Let us delve deeper to find out what to do with ROOT stock now.
Lincoln National Unveils Elite IUL Portfolio With New Growth Features
by Zacks Equity Research
LNC debuts its Elite IUL Portfolio, starting with WealthBuilderSM IUL, offering enhanced S&P-based indices, uncapped options and performance-boosting riders for long-term growth.
Zacks.com featured highlights include Dropbox, CommScope, EverQuote and Willdan
by Zacks Equity Research
Dropbox, CommScope, EverQuote and Willdan have been highlighted in this Screen of The Week article.
Compelling Reasons to Retain Lincoln National Stock Right Now
by Zacks Equity Research
LNC's robust Annuities and Group Protection segments, coupled with new products and a robust financial position, bode well.
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
by Vaishali Doshi
Investors can boost returns by adding top-ranked liquid stocks such as Dropbox, CommScope, EverQuote and Willdan to their portfolios.
Are You Looking for a Top Momentum Pick? Why EverQuote (EVER) is a Great Choice
by Zacks Equity Research
Does EverQuote (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.
MetLife's New Latin America Unit Generates 4.5M Active Customers
by Zacks Equity Research
By leveraging technology and a startup-like agile model, MET aims to scale operations across Latin America.
LNC Unveils Private Market Funds to Meet Clients' Investment Needs
by Zacks Equity Research
Lincoln National partners with Bain Capital and Partners Group to launch two private market funds, enhancing investment options for clients.
AIZ Stock Trading at a Discount to Industry at 2.14X: Time to Hold?
by Zacks Equity Research
Assurant stock rallies on well-performing Global Lifestyle business, growth of fee-based capital-light businesses and effective capital deployment.
Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba
by Zacks Equity Research
DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba have been highlighted in this Screen of The Week article.
EverQuote, Inc. (EVER) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
EverQuote (EVER) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EverQuote (EVER) Surges 5.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
EverQuote (EVER) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.